Current Medical Research and Opinion

Current Medical Research and Opinion 由 Taylor and Francis Ltd. 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 Diabetes Treatment and Management、Diabetes, Cardiovascular Risks, and Lipoproteins、Blood Pressure and Hypertension Studies 等主题的论文，这 3 个主题约占 21.5%，主导子领域为 Endocrinology, Diabetes and Metabolism。（根据 OpenAlex 主题统计与中科院分区数据生成）

Aims and scopeJournal metrics Editorial board Current Medical Research and Opinion (CMRO) is a MEDLINE-indexed, international journal that publishes research focused on new and existing drugs and therapies, best practices in patient care, developments in diagnostic medicine and medical technology, and innovations in medical and scientific publishing. The journal aims to be a platform for high-quality, ethically sound clinical research, as well as provide a forum for guidance on effective and transparent publication and communication of medical research. CMRO welcomes clinically relevant original research and reviews, brief reports, case series, and commentaries across all therapy areas, especially research pertaining to efficacy, equivalence, and safety. The journal also publishes research applicable to standards and practices in medical and scientific publishing. Pharmacoeconomic studies are considered if there is clear clinical relevance. Letters to the Editor and editorials should discuss articles previously published in CMRO. Please note that CMRO does not publish Phase I, pre-clinical, and/or animal studies. CMRO is committed to ensuring the accessibility and readability of medical and scientific literature. The journal encourages submission of plain language summaries, graphical and video abstracts, and infographics. Please see the Instructions for Authors for more information. All manuscripts submitted to the journal are assessed for suitability by the Executive Editor; then peer-reviewed in a single-anonymized fashion. If you would like to send a pre-submission enquiry regarding your manuscript’s suitability for publication, please contact CMRO’s Executive Editor, Dr. Mithi Ahmed. Authors can publish gold open access in this journal and may choose to publish using our Accelerated Publication services. Read full aims and scope

摘自期刊官网 Aims & Scope

研究方向（LetPub）：医学-医学：内科

中科院期刊分区表

数据库收录

SCIEScopusLetPub

国际期刊预警名单：各版本均未列入LetPub

期刊官网自述收录

MEDLINE出版商官网

期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。

影响力指标

影响因子

2.81LetPub · 2026-09-13

CiteScore 2026-06

4.4LetPub · 2026-09-13

SJR 2026-06

0.83LetPub · 2026-09-13

SNIP 2026-06

0.84LetPub · 2026-09-13

h-index

98LetPub · 2026-09-13

h-index

148OpenAlex · 2026-10-01

i10-index

4,566OpenAlex · 2026-10-01

两年平均被引

3.12OpenAlex · 2026-10-01

自引率

3.6%LetPub · 2026-09-13

Gold OA 文章占比

10.13%LetPub · 2026-09-13

发文规模

年文章数

173LetPub · 2026-09-13

不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。

其他来源

平均审稿速度（社区反馈）

一般,3-8周LetPub · 2026-09-13

平均录用比例（社区反馈）

容易LetPub · 2026-09-13

评审方式

单盲同行评审出版商官网

社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。

尚未从任何来源获得费用信息，请以期刊官网为准。

混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。

费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。

摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。

出版商

Taylor and Francis Ltd.

出版国家或地区

ENGLAND

出版语言

English

出版周期

Monthly

创刊年份

1972

ISSN

0300-7995

电子版 ISSN

1473-4877

官网最新一期

Volume 42, Issue 6（2026 年）

官方链接

• 期刊主页 ↗OpenAlex
• 投稿系统 ↗出版商官网
• 专刊 / 特刊征稿 ↗出版商官网